¼¼°èÀÇ ÀÀ°í ¸¶Ä¿ ½ÃÀå º¸°í¼­(2025³â)
Coagulation Markers Global Market Report 2025
»óǰÄÚµå : 1703161
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,344,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,170,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,996,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÀ°í ¸¶Ä¿ ½ÃÀåÀº Ç÷¾× ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº Ç÷¾×ÀÌ Á¦´ë·Î ±â´ÉÇÏ´Â ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ »óŸ¦ Æ÷ÇÔÇϸç, °í·ÉÈ­, ÀνÄÀÇ Çâ»ó, Áø´Ü ´É·Â °­È­ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ±× À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÀ°í ¸¶Ä¿´Â Ç÷¾× ÀÀ°í ±â´É Æò°¡, ÀÌ»ó °¨Áö, Ç÷¿ìº´ ¹× Ç÷ÀüÁõ µîÀÇ Ä¡·á È¿°ú ¸ð´ÏÅ͸µ µî À̵é ÁúȯÀÇ Áø´Ü ¹× °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹éÇ÷º´ Àç´Ü(Leukaemia Foundation)Àº 2024³â 5¿ù, 2035³â±îÁö Ç÷¾×¾ÏÀ̳ª Àå¾Ö¸¦ °¡Áø È£ÁÖÀÎÀÇ ¼ö°¡ 27¸¸ 5,000¸íÀ» ³Ñ¾î¼³ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ¾î ÀÀ°í ¸¶Ä¿¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÀÀ°í ¸¶Ä¿ ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº Ç÷Àü °ü·Ã ÁúȯÀÇ Áø´Ü ¼Óµµ¿Í Á¤È®¼ºÀ» ³ôÀ̱â À§ÇØ D´ÙÀÌ¸Ó Å°Æ®¿Í °°Àº ±â¼úÀûÀ¸·Î Áøº¸µÈ ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, D´ÙÀÌ¸Ó Å°Æ®´Â Ç÷ÀüÀÌ ¿ëÇØµÉ ¶§ »ý¼ºµÇ´Â ´Ü¹éÁú Á¶°¢ÀÎ D´ÙÀ̸ÓÀÇ ¼öÁØÀ» ÃøÁ¤ÇÏ´Â Áø´Ü µµ±¸·Î ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõÀ̳ª Æó»öÀüÁõ°ú °°Àº Ç÷Àü °ü·Ã ÁúȯÀÇ Áø´Ü ¹× Æò°¡¿¡ µµ¿òÀÌ µË´Ï´Ù. Ç÷Àü ¿ëÇØ ½Ã »ý¼ºµÇ´Â ´Ü¹éÁú ´ÜÆíÀÎ D´ÙÀ̸ÓÀÇ ¼öÁØÀ» ÃøÁ¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â Áø´Ü µµ±¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 7¿ù ¹Ì±¹ »ý¸í°øÇÐ ±â¾÷ ¹ÙÀÌ¿À³ëÆ®(Bionote Inc.)´Â Vcheck D-dimer 5Tests/KitÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ¸é¿ª Áø´Ü µµ±¸´Â µ¿¹°¿ëÀ¸·Î ¼³°èµÇ¾úÀ¸¸ç, Ç÷Àü Çü¼º°ú ÆÄ±«ÀÇ Áß¿äÇÑ ¸¶Ä¿ÀÎ D-dimer ¼öÄ¡¸¦ ÃøÁ¤Çϱâ À§ÇØ Å°Æ®´ç 5°¡Áö °Ë»ç¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù. µ¿¹°º´¿ø¿¡¼­ Ç÷ÀüÁõ, ÆÐÇ÷Áõ, DIC µîÀÇ Áø´Ü¿¡ µµ¿òÀÌ µË´Ï´Ù.

2023³â 1¿ù, ¹Ì±¹ »ý¸í°øÇÐ ±â¾÷ ½á¸ðÇǼŠ»çÀ̾ðƼÇÈ(Thermo Fisher Scientific)ÀÌ ¹ÙÀεù »çÀÌÆ® ±×·ì(Binding Site Group)À» ¾à 28¾ï ´Þ·¯(23¾ï ÆÄ¿îµå)¿¡ ÀμöÇß½À´Ï´Ù. À̹ø Àμö´Â Thermo FisherÀÇ Æ¯¼ö Áø´Ü Æ÷Æ®Æú¸®¿À¸¦ °­È­Çϰí, ƯÈ÷ ´Ù¹ß¼º °ñ¼öÁ¾°ú °°Àº ¾Ï Áø´ÜÀ» °­È­ÇÏ¿© ¼ºÀåÇÏ´Â Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ¹ÙÀεù »çÀÌÆ® ±×·ìÀº ¿µ±¹¿¡ º»»ç¸¦ µÐ ÀÇ·á±â±â Á¦Á¶¾÷ü·Î ÀÀ°í ¸¶Ä¿¸¦ °³¹ß, »ý»êÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Coagulation markers are substances in the blood that provide insight into the coagulation or clotting processes. These markers play a crucial role in diagnosing and monitoring various coagulation disorders, assessing the risk of bleeding or thrombosis, and guiding appropriate treatment strategies.

The main products used as coagulation markers include the D-dimer assay and the fibrinogen assay. The D-dimer assay is a blood test that measures the presence of D-dimer, a protein fragment formed when a blood clot breaks down. This test can utilize different sample types such as plasma or whole blood, employing technologies such as fluorescence immunoassay, enzyme-linked immunosorbent assay (ELISA), rapid tests, and particle-enhanced immunoturbidimetric assay. It is applied in conditions such as deep venous thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), trauma, and others. End users of these assays include hospitals, specialty clinics, academic and research institutes, and diagnostic laboratories.

The coagulation markers market research report is one of a series of new reports from The Business Research Company that provides coagulation markers market statistics, including coagulation markers industry global market size, regional shares, competitors with a coagulation markers market share, detailed coagulation markers market segments, market trends and opportunities, and any further data you may need to thrive in the coagulation markers industry. This coagulation markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The coagulation markers market size has grown strongly in recent years. It will grow from $1.16 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the rising prevalence of cardiovascular diseases, an aging population, increasing surgical procedures, awareness and early diagnosis, government initiatives and funding, and expanding healthcare infrastructure.

The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to a growing incidence of chronic diseases, rising adoption of personalized medicine, a growing global population, rising healthcare expenditures, and expansion in emerging markets. Major trends in the forecast period include the integration of AI and machine learning, the development of novel biomarkers, enhanced point-of-care technologies, automation in laboratories, wearable health technologies, telehealth and remote monitoring, and sustainable diagnostic practices.

The coagulation markers market is expected to grow significantly due to the increasing prevalence of blood disorders. These disorders encompass various conditions that impact the blood's ability to function properly, and their prevalence is rising due to factors such as aging populations, improved awareness, and enhanced diagnostic capabilities. Coagulation markers play a crucial role in diagnosing and managing these disorders by evaluating clotting function, detecting abnormalities, and monitoring treatment effectiveness for conditions such as hemophilia and thrombosis. For example, the Leukaemia Foundation reported in May 2024 that the number of Australians living with blood cancers or disorders is projected to surpass 275,000 by 2035, highlighting the escalating demand for coagulation markers.

Leading companies in the coagulation markers market are focusing on creating technologically advanced solutions, such as D-dimer kits, to enhance the speed and accuracy of diagnosing blood clot-related conditions. D-dimer kits are diagnostic tools used to measure the levels of D-dimer, a protein fragment produced during the dissolution of a blood clot, which helps in identifying and evaluating clot-related disorders like deep vein thrombosis and pulmonary embolism. For example, in July 2024, Bionote Inc., a US-based biotechnology firm, launched the Vcheck D-dimer 5Tests/Kit. This immunodiagnostic tool, designed for veterinary use, provides five tests per kit to measure D-dimer levels, a key marker for blood clot formation and breakdown. It helps diagnose conditions such as thrombosis, sepsis, and DIC in veterinary clinics.

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for approximately $2.8 billion (£2.3 billion). This acquisition aims to strengthen Thermo Fisher's Specialty Diagnostics portfolio by enhancing cancer diagnostics, particularly in multiple myeloma, and driving growth in the expanding diagnostics market. The Binding Site Group, a UK-based medical equipment manufacturer, specializes in providing coagulation markers.

Major companies operating in the coagulation markers market are Siemens Healthineers, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Werfen Group, Nihon Kohden Corporation, Randox Laboratories Ltd, Stago Group, Sekisui Diagnostics, Helena Laboratories Italia Spa, Tulip Diagnostics Ltd, Trinity Biotech PLC, CTK Biotech Inc., International Technidyne Corporation (ITC), Diazyme Laboratories Inc., AdvaCare Pharma USA (AccuQuik Test Kits), Technoclone GmbH, BioMedica Diagnostics Inc., Eurolyser Diagnostica GmbH, Goldsite Diagnostics Inc., Hipro Biotechnology Co. Ltd., HYPHEN BioMed

North America was the largest region in the coagulation markers market in 2024. The regions covered in the coagulation markers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coagulation markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coagulation markers market consists of revenues earned by entities providing services such as manufacturing and distribution of coagulation marker testing kits, diagnostic services, research and development of new coagulation markers, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The coagulation markers market also includes sales of coagulation testing kits, point-of-care testing devices, and software solutions for data management and analysis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coagulation Markers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coagulation markers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for coagulation markers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coagulation markers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Coagulation Markers Market Characteristics

3. Coagulation Markers Market Trends And Strategies

4. Coagulation Markers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Coagulation Markers Growth Analysis And Strategic Analysis Framework

6. Coagulation Markers Market Segmentation

7. Coagulation Markers Market Regional And Country Analysis

8. Asia-Pacific Coagulation Markers Market

9. China Coagulation Markers Market

10. India Coagulation Markers Market

11. Japan Coagulation Markers Market

12. Australia Coagulation Markers Market

13. Indonesia Coagulation Markers Market

14. South Korea Coagulation Markers Market

15. Western Europe Coagulation Markers Market

16. UK Coagulation Markers Market

17. Germany Coagulation Markers Market

18. France Coagulation Markers Market

19. Italy Coagulation Markers Market

20. Spain Coagulation Markers Market

21. Eastern Europe Coagulation Markers Market

22. Russia Coagulation Markers Market

23. North America Coagulation Markers Market

24. USA Coagulation Markers Market

25. Canada Coagulation Markers Market

26. South America Coagulation Markers Market

27. Brazil Coagulation Markers Market

28. Middle East Coagulation Markers Market

29. Africa Coagulation Markers Market

30. Coagulation Markers Market Competitive Landscape And Company Profiles

31. Coagulation Markers Market Other Major And Innovative Companies

32. Global Coagulation Markers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coagulation Markers Market

34. Recent Developments In The Coagulation Markers Market

35. Coagulation Markers Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â